Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
Price:
16.75
CNY
0.66%
Market Closed
Market Cap:
¥62.1B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
CN |
|
Watsco Inc
F:WC30
|
US |
|
W
|
Willis Towers Watson PLC
XBER:WTY
|
UK |
|
ArcelorMittal SA
OTC:AMSYF
|
LU |
|
Singapore Airlines Ltd
F:SIA1
|
SG |
|
C
|
Canadian Imperial Bank of Commerce
LSE:0UNI
|
CA |
|
New China Life Insurance Co Ltd
OTC:NWWCF
|
CN |
|
B
|
Baozun Inc
SWB:2BZA
|
CN |
Balance Sheet
Balance Sheet Decomposition
Shanghai Pharmaceuticals Holding Co Ltd
Shanghai Pharmaceuticals Holding Co Ltd
Balance Sheet Decomposition is not available for
Shanghai Pharmaceuticals Holding Co Ltd
Shanghai Pharmaceuticals Holding Co Ltd
Balance Sheet
Shanghai Pharmaceuticals Holding Co Ltd
Shanghai Pharmaceuticals Holding Co Ltd
Currency: CNY
| Dec-2002 | Dec-2003 | Dec-2004 | Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||||
| Cash & Cash Equivalents |
672
|
512
|
430
|
314
|
629
|
629
|
1 037
|
4 887
|
6 511
|
14 850
|
13 525
|
12 979
|
11 609
|
12 039
|
11 967
|
14 842
|
18 694
|
18 083
|
22 227
|
2 072
|
27 238
|
27 500
|
31 881
|
32 607
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
8
|
8
|
8
|
9
|
8
|
11
|
6
|
6
|
8
|
5
|
24 534
|
27 500
|
31 881
|
32 607
|
|
| Cash Equivalents |
672
|
512
|
430
|
314
|
629
|
629
|
1 037
|
4 887
|
6 511
|
14 850
|
13 517
|
12 971
|
11 601
|
12 030
|
11 959
|
14 831
|
18 688
|
18 077
|
22 219
|
2 067
|
2 705
|
0
|
0
|
0
|
|
| Short-Term Investments |
3
|
43
|
92
|
116
|
20
|
36
|
9
|
10
|
4
|
3
|
3
|
0
|
1
|
1
|
4
|
1
|
5
|
3
|
1
|
0
|
9 614
|
11 197
|
10 373
|
10 361
|
|
| Total Receivables |
1 856
|
2 381
|
2 829
|
2 345
|
2 319
|
2 405
|
2 745
|
5 766
|
8 628
|
12 219
|
14 379
|
17 443
|
22 519
|
26 383
|
30 162
|
34 454
|
46 642
|
52 234
|
57 719
|
63 759
|
73 225
|
81 948
|
86 539
|
90 400
|
|
| Accounts Receivables |
1 451
|
1 590
|
1 963
|
1 699
|
2 033
|
2 214
|
2 620
|
4 849
|
6 999
|
10 606
|
12 604
|
15 184
|
19 941
|
24 215
|
27 293
|
31 377
|
42 152
|
47 340
|
52 746
|
58 108
|
66 760
|
72 934
|
79 129
|
82 306
|
|
| Other Receivables |
405
|
791
|
866
|
646
|
286
|
191
|
125
|
917
|
1 629
|
1 613
|
1 775
|
2 259
|
2 578
|
2 168
|
2 869
|
3 077
|
4 490
|
4 894
|
4 973
|
5 651
|
6 465
|
9 014
|
7 409
|
8 093
|
|
| Inventory |
1 170
|
1 358
|
1 223
|
1 351
|
1 364
|
1 364
|
1 623
|
3 701
|
5 233
|
8 297
|
9 810
|
10 997
|
13 088
|
15 091
|
16 416
|
17 270
|
25 024
|
24 877
|
24 088
|
27 104
|
34 460
|
36 623
|
38 944
|
45 359
|
|
| Other Current Assets |
67
|
94
|
175
|
216
|
260
|
346
|
108
|
272
|
1 662
|
626
|
1 085
|
1 097
|
1 443
|
2 071
|
1 719
|
2 075
|
2 912
|
2 894
|
3 528
|
3 427
|
4 975
|
5 166
|
4 087
|
1 737
|
|
| Total Current Assets |
3 768
|
4 388
|
4 751
|
4 342
|
4 591
|
4 781
|
5 523
|
14 637
|
22 038
|
35 996
|
38 802
|
42 515
|
48 658
|
55 585
|
60 267
|
68 642
|
93 278
|
98 092
|
107 563
|
116 494
|
149 513
|
162 434
|
171 823
|
180 464
|
|
| PP&E Net |
1 057
|
1 077
|
1 033
|
945
|
1 370
|
1 130
|
914
|
3 946
|
4 249
|
4 040
|
4 260
|
4 810
|
4 994
|
6 091
|
6 966
|
9 100
|
10 604
|
13 128
|
14 626
|
16 128
|
16 542
|
18 279
|
19 305
|
19 421
|
|
| PP&E Gross |
1 057
|
1 077
|
1 033
|
945
|
1 370
|
1 130
|
914
|
3 946
|
0
|
4 040
|
4 260
|
4 810
|
4 994
|
6 091
|
6 966
|
9 100
|
10 604
|
13 128
|
14 626
|
16 128
|
16 542
|
18 279
|
19 305
|
19 421
|
|
| Accumulated Depreciation |
314
|
374
|
303
|
267
|
441
|
426
|
425
|
2 365
|
0
|
3 058
|
3 416
|
3 732
|
3 753
|
3 920
|
4 187
|
4 643
|
5 267
|
7 481
|
8 820
|
9 760
|
10 773
|
11 969
|
13 013
|
14 372
|
|
| Intangible Assets |
195
|
186
|
147
|
74
|
541
|
526
|
447
|
839
|
897
|
1 276
|
1 407
|
1 540
|
1 862
|
1 984
|
2 767
|
2 702
|
4 283
|
4 142
|
5 419
|
6 309
|
6 587
|
6 361
|
5 833
|
8 847
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
100
|
423
|
2 989
|
3 173
|
3 643
|
4 473
|
4 816
|
5 848
|
6 607
|
11 345
|
10 790
|
11 342
|
11 239
|
11 336
|
11 393
|
11 146
|
12 666
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
50
|
50
|
50
|
93
|
50
|
0
|
0
|
119
|
253
|
333
|
425
|
581
|
316
|
266
|
170
|
198
|
212
|
228
|
386
|
308
|
|
| Long-Term Investments |
333
|
448
|
461
|
962
|
312
|
589
|
748
|
2 034
|
2 219
|
3 022
|
3 007
|
3 144
|
3 229
|
4 249
|
4 826
|
5 125
|
4 954
|
5 725
|
7 898
|
11 049
|
11 724
|
10 917
|
10 201
|
9 000
|
|
| Other Long-Term Assets |
48
|
44
|
48
|
18
|
64
|
50
|
75
|
226
|
289
|
345
|
420
|
541
|
872
|
1 286
|
1 644
|
1 586
|
2 098
|
4 885
|
2 167
|
2 018
|
2 221
|
2 360
|
2 516
|
2 444
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
100
|
423
|
2 989
|
3 173
|
3 643
|
4 473
|
4 816
|
5 848
|
6 607
|
11 345
|
10 790
|
11 342
|
11 239
|
11 336
|
11 393
|
11 146
|
12 666
|
|
| Total Assets |
5 403
N/A
|
6 143
+14%
|
6 440
+5%
|
6 342
-2%
|
6 929
+9%
|
7 126
+3%
|
7 756
+9%
|
21 875
+182%
|
30 163
+38%
|
47 668
+58%
|
51 069
+7%
|
56 312
+10%
|
64 341
+14%
|
74 344
+16%
|
82 743
+11%
|
94 344
+14%
|
126 879
+34%
|
137 026
+8%
|
149 186
+9%
|
163 436
+10%
|
198 135
+21%
|
211 973
+7%
|
221 209
+4%
|
233 149
+5%
|
|
| Liabilities | |||||||||||||||||||||||||
| Accounts Payable |
1 314
|
1 462
|
1 567
|
1 343
|
1 957
|
2 337
|
2 617
|
4 795
|
7 006
|
10 564
|
12 144
|
14 153
|
17 150
|
20 674
|
22 307
|
23 346
|
30 975
|
31 819
|
32 861
|
37 231
|
45 604
|
54 632
|
59 483
|
61 405
|
|
| Accrued Liabilities |
254
|
316
|
276
|
195
|
346
|
272
|
410
|
1 339
|
1 942
|
349
|
553
|
639
|
710
|
773
|
1 017
|
1 222
|
1 187
|
1 561
|
1 348
|
1 656
|
2 588
|
10 950
|
10 895
|
12 346
|
|
| Short-Term Debt |
1 574
|
1 956
|
2 313
|
2 618
|
2 486
|
2 352
|
2 398
|
4 219
|
7 194
|
7 771
|
7 331
|
8 621
|
11 218
|
14 152
|
13 306
|
17 695
|
23 514
|
28 192
|
30 014
|
36 289
|
39 715
|
44 855
|
46 039
|
49 609
|
|
| Current Portion of Long-Term Debt |
0
|
14
|
0
|
0
|
0
|
0
|
0
|
48
|
28
|
1
|
1
|
26
|
21
|
290
|
5
|
6
|
2 007
|
1 186
|
8 885
|
578
|
3 229
|
2 963
|
841
|
2 711
|
|
| Other Current Liabilities |
127
|
153
|
117
|
83
|
182
|
165
|
156
|
643
|
796
|
2 172
|
2 069
|
2 260
|
2 903
|
3 537
|
4 478
|
7 363
|
11 028
|
11 850
|
15 024
|
16 070
|
19 555
|
8 972
|
8 780
|
9 127
|
|
| Total Current Liabilities |
3 269
|
3 901
|
4 273
|
4 238
|
4 970
|
5 127
|
5 582
|
11 044
|
16 966
|
20 856
|
22 098
|
25 699
|
32 003
|
39 427
|
41 113
|
49 632
|
68 710
|
74 608
|
88 133
|
91 824
|
110 691
|
122 372
|
126 038
|
135 198
|
|
| Long-Term Debt |
31
|
90
|
102
|
103
|
3
|
3
|
25
|
84
|
0
|
0
|
2
|
125
|
107
|
94
|
2 864
|
2 982
|
9 638
|
10 290
|
2 685
|
8 592
|
7 561
|
7 336
|
9 728
|
5 394
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
3
|
3
|
1
|
33
|
44
|
266
|
282
|
289
|
380
|
392
|
492
|
620
|
867
|
810
|
832
|
999
|
1 049
|
1 016
|
816
|
1 945
|
|
| Minority Interest |
440
|
398
|
298
|
248
|
350
|
317
|
401
|
2 153
|
2 819
|
2 903
|
3 062
|
3 047
|
3 277
|
3 878
|
5 212
|
5 645
|
7 420
|
7 727
|
9 386
|
9 707
|
10 939
|
11 802
|
12 067
|
13 896
|
|
| Other Liabilities |
40
|
43
|
28
|
23
|
30
|
35
|
58
|
278
|
326
|
564
|
985
|
1 198
|
752
|
623
|
1 439
|
1 434
|
1 231
|
1 933
|
2 794
|
2 954
|
831
|
923
|
885
|
824
|
|
| Total Liabilities |
3 780
N/A
|
4 431
+17%
|
4 701
+6%
|
4 613
-2%
|
5 356
+16%
|
5 484
+2%
|
6 066
+11%
|
13 593
+124%
|
20 154
+48%
|
24 589
+22%
|
26 430
+7%
|
30 358
+15%
|
36 518
+20%
|
44 414
+22%
|
51 120
+15%
|
60 314
+18%
|
87 866
+46%
|
95 367
+9%
|
103 831
+9%
|
114 076
+10%
|
131 072
+15%
|
143 448
+9%
|
149 534
+4%
|
157 257
+5%
|
|
| Equity | |||||||||||||||||||||||||
| Common Stock |
316
|
474
|
474
|
474
|
474
|
569
|
569
|
569
|
1 993
|
2 689
|
2 689
|
2 689
|
2 689
|
2 689
|
2 689
|
2 689
|
2 842
|
2 842
|
2 842
|
2 842
|
3 698
|
3 703
|
3 708
|
3 708
|
|
| Retained Earnings |
495
|
567
|
592
|
577
|
428
|
490
|
542
|
2 753
|
4 175
|
5 910
|
7 520
|
9 081
|
10 968
|
13 060
|
15 354
|
17 900
|
20 819
|
23 639
|
26 880
|
30 591
|
34 639
|
36 129
|
38 854
|
43 029
|
|
| Additional Paid In Capital |
812
|
671
|
672
|
679
|
665
|
579
|
578
|
4 954
|
3 846
|
14 490
|
14 446
|
14 204
|
14 152
|
14 146
|
13 558
|
13 507
|
15 845
|
15 721
|
15 898
|
16 071
|
29 098
|
29 188
|
29 648
|
29 687
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
18
|
27
|
42
|
53
|
|
| Other Equity |
0
|
0
|
0
|
0
|
6
|
3
|
1
|
6
|
5
|
10
|
16
|
19
|
13
|
35
|
21
|
65
|
493
|
542
|
265
|
144
|
390
|
469
|
492
|
480
|
|
| Total Equity |
1 623
N/A
|
1 712
+5%
|
1 739
+2%
|
1 728
-1%
|
1 573
-9%
|
1 641
+4%
|
1 689
+3%
|
8 282
+390%
|
10 010
+21%
|
23 078
+131%
|
24 639
+7%
|
25 954
+5%
|
27 822
+7%
|
29 930
+8%
|
31 623
+6%
|
34 031
+8%
|
39 014
+15%
|
41 659
+7%
|
45 355
+9%
|
49 359
+9%
|
67 063
+36%
|
68 524
+2%
|
71 676
+5%
|
75 891
+6%
|
|
| Total Liabilities & Equity |
5 403
N/A
|
6 143
+14%
|
6 440
+5%
|
6 342
-2%
|
6 929
+9%
|
7 126
+3%
|
7 756
+9%
|
21 875
+182%
|
30 163
+38%
|
47 668
+58%
|
51 069
+7%
|
56 312
+10%
|
64 341
+14%
|
74 344
+16%
|
82 743
+11%
|
94 344
+14%
|
126 879
+34%
|
137 026
+8%
|
149 186
+9%
|
163 436
+10%
|
198 135
+21%
|
211 973
+7%
|
221 209
+4%
|
233 149
+5%
|
|
| Shares Outstanding | |||||||||||||||||||||||||
| Common Shares Outstanding |
569
|
569
|
569
|
569
|
569
|
569
|
569
|
569
|
1 993
|
2 689
|
2 689
|
2 689
|
2 689
|
2 689
|
2 689
|
2 689
|
2 842
|
2 842
|
2 842
|
2 842
|
3 698
|
3 703
|
3 708
|
3 708
|
|
Switch to:
Switch to:
Continue Research
Other Shanghai Pharmaceuticals Holding Co Ltd listings:
Discover More
